173 related articles for article (PubMed ID: 34025617)
1. A Chimeric Cationic Peptide Composed of Human β-Defensin 3 and Human β-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance.
Yu W; Ning N; Xue Y; Huang Y; Guo F; Li T; Yang B; Luo D; Sun Y; Li Z; Wang J; He Z; Cheng S; Zhang X; Wang H
Front Microbiol; 2021; 12():663151. PubMed ID: 34025617
[TBL] [Abstract][Full Text] [Related]
2. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.
Li T; Guo F; Wang Q; Fang H; Li Z; Wang D; Wang H
PLoS One; 2015; 10(2):e0117913. PubMed ID: 25706284
[TBL] [Abstract][Full Text] [Related]
3. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains.
Routsias JG; Karagounis P; Parvulesku G; Legakis NJ; Tsakris A
Peptides; 2010 Sep; 31(9):1654-60. PubMed ID: 20600430
[TBL] [Abstract][Full Text] [Related]
4. A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.
Olli S; Nagaraj R; Motukupally SR
Antimicrob Agents Chemother; 2015 Jan; 59(1):217-25. PubMed ID: 25348533
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of human β-defensins against lactic acid bacteria.
Wang XF; Tian F; Cao RM; Li J; Wu SM; Guo XK; Chen TX
Nat Prod Res; 2015; 29(22):2164-6. PubMed ID: 25560646
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
Supp DM; Gardner J; Klingenberg JM; Neely AN
Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Peptides Epinecidin-1 and Beta-Defesin-3 Are Effective against a Broad Spectrum of Antibiotic-Resistant Bacterial Isolates and Increase Survival Rate in Experimental Sepsis.
Bolatchiev A
Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052952
[TBL] [Abstract][Full Text] [Related]
8. Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.
Scudiero O; Galdiero S; Nigro E; Del Vecchio L; Di Noto R; Cantisani M; Colavita I; Galdiero M; Cassiman JJ; Daniele A; Pedone C; Salvatore F
Antimicrob Agents Chemother; 2013 Apr; 57(4):1701-8. PubMed ID: 23357761
[TBL] [Abstract][Full Text] [Related]
9. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains.
Maisetta G; Batoni G; Esin S; Florio W; Bottai D; Favilli F; Campa M
Antimicrob Agents Chemother; 2006 Feb; 50(2):806-9. PubMed ID: 16436752
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3.
Nuding S; Zabel LT; Enders C; Porter E; Fellermann K; Wehkamp J; Mueller HA; Stange EF
Microbes Infect; 2009 Mar; 11(3):384-93. PubMed ID: 19397883
[TBL] [Abstract][Full Text] [Related]
11. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore EV; Park CH; Quayle AJ; Wiles KR; McCray PB; Ganz T
J Clin Invest; 1998 Apr; 101(8):1633-42. PubMed ID: 9541493
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.
Huang LC; Redfern RL; Narayanan S; Reins RY; McDermott AM
Antimicrob Agents Chemother; 2007 Nov; 51(11):3853-60. PubMed ID: 17724155
[TBL] [Abstract][Full Text] [Related]
13. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals R; Wang X; Wu Z; Freeman T; Bafna V; Zasloff M; Wilson JM
J Clin Invest; 1998 Sep; 102(5):874-80. PubMed ID: 9727055
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of renal tubular cells: the putative role of human beta-defensins.
Nitschke M; Wiehl S; Baer PC; Kreft B
Exp Nephrol; 2002; 10(5-6):332-7. PubMed ID: 12381917
[TBL] [Abstract][Full Text] [Related]
15. [A study of human beta-defensin-1 and human beta-defensin-2 in airway mucosal defense].
Hiratsuka T; Nakazato M; Ashitani J; Matsukura S
Kansenshogaku Zasshi; 1999 Feb; 73(2):156-62. PubMed ID: 10213993
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of human defensins against
Bolatchiev A
PeerJ; 2020; 8():e10455. PubMed ID: 33304659
[TBL] [Abstract][Full Text] [Related]
17. Detection of natural peptide antibiotics in human nasolacrimal ducts.
Paulsen FP; Pufe T; Schaudig U; Held-Feindt J; Lehmann J; Schröder JM; Tillmann BN
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2157-63. PubMed ID: 11527925
[TBL] [Abstract][Full Text] [Related]
18. Human defensins.
Schneider JJ; Unholzer A; Schaller M; Schäfer-Korting M; Korting HC
J Mol Med (Berl); 2005 Aug; 83(8):587-95. PubMed ID: 15821901
[TBL] [Abstract][Full Text] [Related]
19. A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus.
Rajamuthiah R; Jayamani E; Conery AL; Fuchs BB; Kim W; Johnston T; Vilcinskas A; Ausubel FM; Mylonakis E
PLoS One; 2015; 10(6):e0128576. PubMed ID: 26062137
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
